Codexis to Restructure and Give Up 36,000 SQFT Lease at Alexandria’s District for Science & Technology in San Carlos

By The Registry Staff Codexis Inc., a Redwood City-based company (NASDAQ: CDXS), has announced significant changes to its operations and strategic focus. The company plans to discontinue all preclinical discovery work in gene therapy and other biotherapeutics. This decision will lead to a consolidation effort, resulting in a reduction of about 25 percent of its […]